In summary, the immune profile analysis of a refined cohort of IDH wild type GBM cases revealed that high densities of proliferating CD8+ T-cells and high ratio of CD8+ to CD4+ cells correlated with improved survival. The gene discussed is IDH1; the disease is glioblastoma.